£100m mkt cap17 Feb 2023 06:50
Not sure how this share doesn’t have a mkt cap of at least £100m+
The prostate test alone I’m sure, even now, would fetch £250m. It’s unrivalled
14% accuracy vs 94%. This test will be the standard throughout the whole world. What value do you put on that?
13 out of every 100 men get prostate cancer. That means you’d likely need to test 50%, at the absolute least, of the entire population of America. Then there’s the U.K. and the rest of Europe.
Unrivalled test will be the standard, has to be as it will save lives & money